Anika Therapeutics Inc. · NASDAQ:ANIK
Vanguard Capital Management LLC's stake in Anika Therapeutics Inc. fell to 4.95% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 31, 2026
Vanguard Capital Management LLC's stake in Anika Therapeutics Inc. fell to 4.95%, 659,216 shares, as a passive investor on Jun 30, 2026. Filed Jul 31, 2026 (Schedule 13G/A).
- Stake
- 4.95%
- Shares
- 659,216
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 4.95% | 659,216 |
Source
Related
- Anika Therapeutics Inc.
- Vanguard Capital Management LLC
- Anika Therapeutics Inc. shareholders
- Schedule 13G · Vanguard Capital Management LLC · Apr 29, 2026
- Form 4 · Fischetti Gary P · Aug 5, 2026
- Schedule 13G/A · BlackRock Portfolio Management LLC · Jul 17, 2026
- Form 4 · Fischetti Gary P · Jun 23, 2026
- Form 4 · Henneman John B III · Jun 23, 2026
- Form 4 · Richard Stephen · Jun 23, 2026